Novavax News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

01.08.22	Novavax to Host Conference Call to Discuss Second Quarter 2022 Financial Results and Operational Highlights on August 8, 2022 (PR Newswire)
26.07.22	Novavax: Nuvaxovid COVID-19 Vaccine Now Approved For Use In Adolescents In Japan (RTTNews)
26.07.22	Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan (PR Newswire)
26.07.22	Novavax Nuvaxovid™ COVID-19 Vaccine Granted Provisional Registration in Australia for Use in Adolescents Aged 12 Through 17 (PR Newswire)
19.07.22	U.S. CDC Advisory Committee Unanimously Recommends Novavax COVID-19 Vaccine, Adjuvanted as a Primary Series for Individuals Aged 18 and Older (PR Newswire)
19.07.22	Novavax Enters Agreements With SK Bioscience For Manufacturing, Supply Of NVX-CoV2373 (RTTNews)
19.07.22	Novavax Announces Expanded Agreement with SK bioscience to Manufacture COVID-19 Vaccine Containing Omicron Variant and Manufacture the Novavax COVID-19 Vaccine in Prefilled Syringes (PR Newswire)
13.07.22	U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over (PR Newswire)
11.07.22	U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine (PR Newswire)
05.07.22	Novavax's Nuvaxovid COVID-19 Vaccine Conditionally Authorized In EU For Adolescents Aged 12 To 17 (RTTNews)
05.07.22	Novavax Nuvaxovid™ COVID-19 Vaccine Conditionally Authorized in the European Union for Adolescents Aged 12 Through 17 (PR Newswire)
29.06.22	Novavax's Prototype Vaccine Shows Broad Immune Responses Incl. Against Omicron And Other Variants (RTTNews)
29.06.22	Novavax COVID-19 Data Presented at FDA VRBPAC Meeting Demonstrates Broad Antibody Responses to Both Prototype and Omicron-Specific Variants (PR Newswire)
24.06.22	Novavax COVID-19 Vaccine Recommended For Conditional Marketing Authorization In EU For Adolescents (RTTNews)
24.06.22	Novavax' Nuvaxovid COVID-19 Vaccine Gets Emergency Use Authorization In Taiwan For Use In Adults (RTTNews)
23.06.22	Novavax' Nuvaxovid™ COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan for Use in Individuals Aged 18 and Over (PR Newswire)
23.06.22	Novavax COVID-19 Vaccine Nuvaxovid™ Recommended for Expanded Conditional Marketing Authorization in the European Union by CHMP for Adolescents Aged 12 Through 17 (PR Newswire)
13.06.22	Novavax Granted Provisional Registration For Nuvaxovid As Booster In Australia (RTTNews)
13.06.22	Novavax COVID-19 Vaccine Nuvaxovid™ Provisionally Registered in Australia as a Booster in Individuals Aged 18 and Over (PR Newswire)
08.06.22	Pre-market Movers: XCUR, CYRN, EFOI, NVAX, AERC… (RTTNews)
08.06.22	FDA Advisory Committee Recommends Emergency Use Authorization For Novavax COVID-19 Vaccine (RTTNews)
07.06.22	FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older (PR Newswire)
10.05.22	Pre-market Movers: UPST, FF, NVAX, KOSS, DTST… (RTTNews)
09.05.22	Novavax Inc. Q1 Earnings Summary (RTTNews)
09.05.22	Novavax Reports First Quarter 2022 Financial Results and Operational Highlights (PR Newswire)
04.05.22	Novavax to Participate in BofA Securities 2022 Healthcare Conference (PR Newswire)
02.05.22	Novavax to Host Conference Call to Discuss First Quarter 2022 Financial Results and Operational Highlights on May 9, 2022 (PR Newswire)
30.04.22	FDA Panel To Review Novavax COVID-19 Vaccine In June (RTTNews)
29.04.22	FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Novavax' COVID-19 Vaccine (PR Newswire)
22.04.22	Novavax Administers First Doses Of COVID-19 Vaccine Booster In Adolescents In Phase 3 Trial (RTTNews)
22.04.22	Novavax Announces Initiation of COVID-19 Vaccine Booster Study in Adolescents in Phase 3 PREVENT-19 Trial (PR Newswire)
20.04.22	Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine (PR Newswire)
19.04.22	Novavax' Covid-19 Vaccine Gets Approval In Japan (RTTNews)
19.04.22	Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan (PR Newswire)
19.04.22	Takeda : Japan Approves Nuvaxovid COVID-19 Vaccine For Primary And Booster Immunization (RTTNews)
18.04.22	Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases (PR Newswire)
13.04.22	Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine (PR Newswire)
08.04.22	Novavax, Serum Institute Get Emergency Use Authorization For Covid Vaccine In Thailand (RTTNews)
08.04.22	Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand (PR Newswire)
31.03.22	Novavax Files To Expand CMA In The EU Of Nuvaxovid Vaccine To Include Adolescents Aged 12-17 Years (RTTNews)
31.03.22	Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17) (PR Newswire)
25.03.22	Novavax: NVX-CoV2373 Now Participating In Two COVID-19 Booster Studies (RTTNews)
25.03.22	Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine (PR Newswire)
23.03.22	Novavax's Covid-19 Vaccine Gets Emergency Use Nod In India For Adolescents (RTTNews)
22.03.22	Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India (PR Newswire)
10.03.22	Novavax Announces Launch of Global Vaccine Education Programs (PR Newswire)
02.03.22	Novavax to Participate in Cowen's 42nd Annual Health Care Conference (PR Newswire)
28.02.22	Novavax Inc. Q4 Loss increases, misses estimates (RTTNews)
28.02.22	Novavax Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights (PR Newswire)
28.02.22	Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical Trial (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		S&P 500-Handel aktuell: S&P 500 liegt letztendlich im Plus
22.11.24		Freundlicher Handel: NASDAQ 100 verbucht zum Ende des Freitagshandels Zuschläge
22.11.24		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
22.11.24		Gewinne in New York: NASDAQ 100 präsentiert sich fester
22.11.24		Gute Stimmung in New York: nachmittags Pluszeichen im S&P 500
22.11.24		Starker Wochentag in New York: S&P 500 zeigt sich am Mittag fester
22.11.24		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

S&P 500-Handel aktuell: S&P 500 liegt letztendlich im Plus

22.11.24

Freundlicher Handel: NASDAQ 100 verbucht zum Ende des Freitagshandels Zuschläge

22.11.24

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

22.11.24

Gewinne in New York: NASDAQ 100 präsentiert sich fester

22.11.24

Gute Stimmung in New York: nachmittags Pluszeichen im S&P 500